Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director comp.
Appointed director

Compass Therapeutics, Inc. (CMPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Investor Contact"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/24/2023 8-K Quarterly results
03/15/2023 10-K Annual Report for the period ended December 31, 2022
03/10/2023 4 Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Bought 10,000 shares @ $3.37, valued at $33.7k
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/27/2023 4 Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Bought 20,000 shares @ $3.98, valued at $79.6k
02/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 4.2% stake in Compass Therapeutics, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/10/2023 8-K Quarterly results
02/09/2023 4 Chiniara Ellen (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $3.93, valued at $157.2k
02/09/2023 4 GRAY MARY ANN (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $3.93, valued at $157.2k
02/09/2023 4 GORDON CARL L (10% Owner) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $3.93, valued at $235.8k
02/09/2023 4 Ferneau Philip (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $3.93, valued at $196.5k
02/09/2023 4 Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 500,000 shares @ $0
Granted 700,000 options to buy @ $3.93, valued at $2.8M
02/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 SC 13G/A FMR LLC reports a 5% stake in COMPASS THERAPEUTICS INC
01/31/2023 4 Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Bought 20,000 shares @ $4.05, valued at $81k
01/24/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/24/2023 4 Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Bought 20,000 shares @ $4.19, valued at $83.8k
01/23/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
12/02/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
11/29/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy